Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

From the monthly archives: September, 2019

We are pleased to present below all posts archived in 'September, 2019'. If you still can't find what you are looking for, try using the search box.

AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy

Targeted cancer therapy represents a promising new cancer treatment, one which delivers drugs in specific carriers and interferes with the specific target molecules that play a critical role in tumour growth and progression.

Read the rest of entry »

Ardington Archives LLP - Celebrating 25 years of secure document management

Ardington Archives LLP is celebrating 25 years providing secure storage of archive documents.  From its beginnings in the downland village of Ardington, the company has grown to 3 facilities in Oxfordshire, providing bespoke document storage and management to clients across a wide range of business sectors.

Read the rest of entry »

Upperton Pharma Solutions Investment Increases Tabletting Capabilities

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) has significantly increased its tablet manufacturing capabilities following a strategic investment in a new state-of the-art tablet press.

Read the rest of entry »

AMSBIO: Host Cell Protein ELISA Detection Kits

AMSBIO has launched a range of ELISA Host Cell Protein (HCP) detection kits that allow you to detect the presence of host cell protein impurities in your therapeutic at any phase of your product development.

Read the rest of entry »

Technology Support Programme: Targeted population solutions for improved Diabetes control.

The companies successfully accepted into the programme will benefit from a committed NHS research partnership and trial support to deliver a clinical study within the NHS. 

Read the rest of entry »

The diagnostic chronic lymphocytic leukaemia genome by nanopore sequencing

Chronic lymphocytic leukaemia (CLL) is characterised by specific genomic alterations, including mutations at the IgHV locus and within TP53, and deletions of chromosome 17p. Current screening methods (e.g. FISH and Sanger sequencing) for these predictive biomarkers are limited in terms of cost, speed and sensitivity; short-read sequencing is limited by platform costs, poor read mapping, and GC bias.

Read the rest of entry »

OBN Announce Collaboration with ProcEurope Limited, a Purchasing Consortium for Europe

Abingdon, UK; 2nd September 2019 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce a collaboration with ProcEurope Limited.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.